Raúl J. Andrade Bellido-rekin lankidetzan egindako argitalpenak (7)

2024

  1. Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet

    Pharmacological Research, Vol. 200

2022

  1. Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

    Cell death & disease, Vol. 13, Núm. 2, pp. 143

  2. Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen

    Antioxidants, Vol. 11, Núm. 5

2021

  1. Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]

    Journal of Hepatology, Vol. 75, Núm. 4, pp. 935-959

  2. Oxidative stress in drug-induced liver injury (Dili): From mechanisms to biomarkers for use in clinical practice

    Antioxidants, Vol. 10, Núm. 3, pp. 1-35

2019

  1. Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury

    Journal of Pathology, Vol. 247, Núm. 1, pp. 110-122

2018

  1. High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries

    Clinical Gastroenterology and Hepatology